Sun Pharmaceutical Industries retained its position as India's largest pharmaceutical company in October 2026, recording moving annual total (MAT) sales of Rs 22,653 crore and 14.7 per cent value growth, according to Pharmarack Technologies data.
Sun Pharma accounted for 8.5 per cent of the Indian Pharmaceutical Market (IPM), maintaining a significant lead over its competitors. Abbott ranked second with MAT sales of Rs 16,229 crore, contributing 6.1 per cent to the market and recording 10.7 per cent growth.
Mankind Pharma secured the third position with sales of Rs 15,926 crore and 13.1 per cent growth. Cipla ranked fourth, recording Rs 15,099 crore in sales and 10.6 per cent growth. Torrent Pharmaceuticals occupied the fifth position, with sales of Rs 13,496 crore and 15.8 per cent growth.
Intas Pharmaceuticals ranked sixth with MAT sales of Rs 10,657 crore, registering 14.9 per cent growth. Alkem Laboratories followed in seventh position with sales of Rs 10,828 crore and 11 per cent growth.
Lupin recorded MAT sales of Rs 9,337 crore, registering 12.7 per cent growth, while Zydus Lifesciences ranked ninth with sales of Rs 8,386 crore and 15.4 per cent growth. Dr. Reddy's Laboratories completed the top 10 with sales of Rs 8,293 crore and 12.4 per cent growth.
Among the top 10 corporations, Torrent Pharmaceuticals recorded the highest MAT growth at 15.8 per cent, closely followed by Zydus Lifesciences at 15.4 per cent. Sun Pharma also recorded strong growth of 14.7 per cent while maintaining its market leadership.
Overall, the IPM recorded MAT sales of Rs 2,66,510 crore in October 2026, representing 11.3 per cent growth.
Top 10 pharma corporates – MAT October 2026
|
Rank |
Corporate |
MAT sales (Rs Cr) |
Market share |
MAT value growth |
|
1 |
Sun Pharma |
22,653 |
8.5% |
14.7% |
|
2 |
Abbott |
16,229 |
6.1% |
10.7% |
|
3 |
Mankind Pharma |
15,926 |
6.0% |
13.1% |
|
4 |
Cipla |
15,099 |
5.7% |
10.6% |
|
5 |
Torrent Pharma |
13,496 |
5.1% |
15.8% |
|
6 |
Intas |
10,657 |
4.0% |
14.9% |
|
7 |
Alkem |
10,828 |
4.1% |
11.0% |
|
8 |
Lupin |
9,337 |
3.5% |
12.7% |
|
9 |
Zydus Lifesciences |
8,386 |
3.1% |
15.4% |
|
10 |
Dr. Reddy's |
8,293 |
3.1% |
12.4% |
Narayan Kulkarni